This scatter plot that shows the number of mice still alive through the course of treatment (Survival Rate). After 45 days treatment, 84% of mice (21) in the Capomulin group treatment are still alive while the survival rate for Placebo group is 44% (11 mice). Survival rates for Ketapril and Infubinol are similarly to the Placebo treatment. Capomulin is the drug presenting the higher survival rate during the treatment.